To this end, human MM cell lines already characterized for the expression NKG2D and DNAM-1 ligands [(SKO-007(J3) and RPMI-8226)] [49, 50] were treated with CX-5461 or BMH-21. This evidence concerns the gene CD226 and Miyoshi myopathy.